- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04110808
Comparative Effect of Hypotensive Anaesthesia on Event Related Potentials, Quantitative Electroencephalograghy
Comparative Effect of Hypotensive Anaesthesia Using Nitroglycerine vs Phentolamine on Event Related Potentials, Quantitative Electroencephalograghy and Cognitive Function in Patients Undergoing Septoplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
METHODS:
Study design and population: This is a pilot prospective randomized clinical trial that will be carried out on 60 patients candidate for septoplasty subjected to general hypotensive anaesthesia. The patients will be recruited from Ear, nose and throat surgery department, Beni-Suef University Hospital. All the participants will be required to offer a written informed consent
Sampling Technique:
Patients will be randomly assigned into one of two equal groups; the first group will receive nitroglycerine (30 participants) (nitroglycerine group) and the second group will receive phentolamine (30 participants) (phentolamine group). Randomization will be carried out using a closed opaque envelope technique with the anesthetist will pick up a sealed envelope which contains a paper with the name of the group to which the patient will be randomized is written. Whichever the group written on the paper, the patient will be scheduled to it.
All included patients will be subjected to the following:
1) Cognitive assessment:
Cognitive functions for the patients will be assessed (preoperative and 1 week postoperative) using the following psychometric tests:
Paired Associate Learning test (PALT) Aim: to assess auditory verbal memory. The test uses the concept of semantic cueing
.
- Benton Visual Retention test (BVRT) Aim: to assess visual perceptual, visual memory, visual motor and visuoconstructive abilities.
2) Neurophysiological assessment: Digital Electroencephalograghy (EEG), quantitative Electroencephalograghy (QEEG) and Event related potentials (ERPs) and will be done for all included patients (preoperative and 1 week postoperative).
Statistical analysis The sample size will be calculated using G*Power version 3.1.9.2 Software based on this pilot study. The probability of type I error (α) will be 5%, and the statistical power (1-β) should exceed 80%. The data will be coded and entered using: the statistical package for social science version 15 (SPSS v 15). Descriptive statistics will be reported as mean ± SD and number (%) for categorical variables. Student t- test will be used for comparison between means of two unpaired groups of quantitative variables. Paired sample t- test will be used for comparison between means of two paired groups of quantitative variables. Chi square test will be used for comparison between two groups of categorical data. Mixed ANOVA test will be used for comparing paired data in two unpaired groups. The probability/significance value (P value) ≥ 0.05 is not statistically significant and <0.05 is statistically significant.
Study Type
Enrollment (Anticipated)
Phase
- Early Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who are candidate for septoplasty
- Patients from both sexes, aged between 20-50 years
Exclusion Criteria:
- Patients who develop intraoperative shock or major bleeding
- Patients with ischemic heart diseases, heart block, congestive heart failure, valvular heart diseases, or uncontrolled hypertension
- Patients with a history of central neurological system disorder
- Patients with concomitant medical or metabolic illness known to affect cognition
- Pregnant females
- Allergy to any of the anaesthetic or hypotensive drugs used in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Nitroglycerine
Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100μg/ml at the rate of 0.5- 10 μg/kg/min according to the patients desired target blood pressure.
|
effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function Phentolamine group (30 patients): Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure. Nitroglycerine group (30 patients): Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100μg/ml at the rate of 0.5- 10 μg/kg/min according to the patients desired target blood pressure.
Other Names:
|
|
Other: Phentolamine
Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure.
|
effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine on Event related potentials, quantitative Electroencephalograghy and cognitive function Phentolamine group (30 patients): Patients will receive hypotensive anesthesia with phentolamine infusion via syringe pump by adding 20 mg (2ml) of Phentolamine to 48 ml of normal saline making it to final concentration of 0.4 mg/ml at the rate of 0.1-2 mg/min according to the patients desired target blood pressure. Nitroglycerine group (30 patients): Patients will receive hypotensive anesthesia with nitroglycerine infusion via syringe pump by adding 5mg (5ml) of Nitroglycerin to 45ml of normal saline making it to final concentration of 100μg/ml at the rate of 0.5- 10 μg/kg/min according to the patients desired target blood pressure.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Paired Associate Learning test for assessment of Cognitive function
Time Frame: 1 week
|
Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine
|
1 week
|
|
Benton Visual Retention test for assessment of Cognitive function
Time Frame: 1 week
|
Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative Electroencephalograghy for assessment of electrical activity of the brain
Time Frame: 1 week
|
Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine
|
1 week
|
|
Event related potentials (ERP ) P300 for neurophysiological assessment of cognition
Time Frame: 1 week
|
Comparative effect of hypotensive anaesthesia using Nitroglycerine vs Phentolamine
|
1 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- hypotensive anaesthesia
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Effect of Drugs
-
Tanta UniversityUnknown
-
Suez Canal UniversityUnknown
-
First Affiliated Hospital of Zhejiang UniversityBeijing Xuze Medical Technology Co., LTD.CompletedSafety Issues | Effect of DrugsChina
-
First Affiliated Hospital of Zhejiang UniversityJiangsu Aosaikang Pharmaceutical Co., Ltd.UnknownSafety Issues | Effect of DrugsChina
-
First Affiliated Hospital of Zhejiang UniversityBeijing Xuze Medical Technology Co., LTD.CompletedSafety Issues | Effect of DrugsChina
-
David VivasSt Carlos Hospital, Madrid, SpainCompletedStudy of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate (ECCLIPSE)Adverse Effect of Antithrombotic DrugsSpain
-
Chun PanSoutheast University, ChinaUnknownThe Effect of Analgesic Drugs on Respiratory CenterChina
-
Atlas Molecular PharmaCompletedAdverse Effect of Drugs and Medicaments in Therapeutic UseUnited States
-
Jinnah Postgraduate Medical CentreCompletedEffect of Drugs | Adverse Effects of Medical DrugsPakistan
-
Albert Einstein College of MedicineCompleted
Clinical Trials on hypotensive anaesthesia using Nitroglycerine
-
Ankara Yildirim Beyazıt UniversityRecruitingHypersensitivity | Molar Incisor HypomineralizationTurkey (Türkiye)
-
Assistance Publique - Hôpitaux de ParisCompletedDeep Caries | Molar Incisor HypomineralisationFrance
-
University of LjubljanaCompletedPostoperative ComplicationsSlovenia
-
Rajiv Gandhi Cancer Institute & Research Center...CompletedSevoflurane | DesfluraneIndia
-
The First Affiliated Hospital of Xiamen UniversityActive, not recruitingHepatic Cancer | Hepatic NeoplasmChina
-
Ain Shams UniversityRecruitingHypotensive Anesthesia | Ear, Nose and Throat ProcedureEgypt